Table 3.
Dosage, onset of action and adverse events of eszopiclone in non-elderly and elderly subjects with chronic primary insomnia
| Non-elderly subjectsa | Elderly subjectsb | |
|---|---|---|
| Dosage (mg) | 2–3 | 1–2 |
| Onset of action (h) | 0.5–1 | 0.5–1 |
| Adverse events | unpleasant taste | headache |
| viral infection | urinary tract infection | |
| headache | unpleasant taste | |
| somnolence | dry mouth | |
| dry mouth | dizziness | |
| dizziness | pain | |
| dyspepsia | accidental injury | |
| nausea | diarrhea | |
| rash | nervousness | |
| anxiety | neuralgia | |
| respiratory infection | ||
| confusion |
a
Non-elderly subjects: 3 mg – n = 106
b
Elderly subjects: 2 mg – n = 215